TP53 and cancer: Activation of the AMPK/mTOR/HIF-1α loop-signaling pathway has been identified as the key anti-cancer mechanism to mediate metabolic check-points such as p53 and p21, and induced cell death modes in apoptosis and autophagy upon these cytotoxic drug treatments [40].